BeStock  
Stocks › Biotechnology › CGEM

Cullinan Therapeutics CGEM

US equityMarket cap rank #3236Biotechnology
$15.63 −$0.62 (-3.82%)
Pre-market · Oct 8, 8:20 am ET · After hours $15.63 0.00%
Open$15.95
Prev close$16.25
Day range$15.47 – $16.46
Volume808.2K
Market cap$1.01B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-5.0x
CheapRich

Below its usual level · 33rd percentile, 5-year average -3.1x

Price / book3.1x
CheapRich

Near the top of its 5-year range · 97th percentile, 5-year average 1.4x

#3729 of 5317 stocks by PB (1 = cheapest)

Price / sales53.1x
CheapRich

Near the top of its 5-year range · 88th percentile, 5-year average 35.1x

#4848 of 5146 stocks by PS (1 = cheapest)

P/E over five years

-25x-12x0x13xOct '21Apr '24Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$15.35
Price vs. fair value+1.8%Close to the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 3.13 – 1.43 97% (pricier than usual) #3729 of 5317 (1 = cheapest)
PE -5.03 -4.89 -3.07 33% (cheaper than usual) –
PS 53.10 34.54 35.10 88% (pricier than usual) #4848 of 5146 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$15.35
Economic moatNone
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on CGEM.

Leave a comment

Scroll to Top